Association Between Filgrastim Biosimilar Availability and Changes in Claim Payments and Patient Out-of-Pocket Costs for Biologic Filgrastim Products
Morgane C. Mouslim, Antonio J. Trujillo, G. Caleb Alexander, Jodi B Segal
Topics & Concepts
FilgrastimBiosimilarMedicinePaymentCost sharingMedical prescriptionBusinessInternal medicinePharmacologyGranulocyte colony-stimulating factorFinanceChemotherapyNursingBiosimilars and Bioanalytical MethodsNeutropenia and Cancer InfectionsMedication Adherence and Compliance